[Evaluation study of lividomycin in pediatrics].
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006801:Humans; D007223:Infant; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D008826:Microbial Sensitivity Tests; D011014:Pneumonia / Q000188:drug therapy*; D011023:Pneumonia, Staphylococcal / Q000188:drug therapy; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents